The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

Stage

Grant - II | Alive

Total Raised

$150K

Last Raised

$150K | 6 yrs ago

About RespiDx

RespiDx develops medical diagnostic equipment for early detection of Pneumonia - the primary cause of child mortality in the developing world.

RespiDx Headquarter Location

Jerusalem,

Israel

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing RespiDx

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

RespiDx is included in 2 Expert Collections, including Medical Devices.

M

Medical Devices

8,082 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

H

Health IT

7,900 items

RespiDx Patents

RespiDx has filed 1 patent.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

1/28/2016

Intensive care medicine, Respiratory therapy, Respiratory physiology, Attachment theory, Medical signs

Application

Application Date

1/28/2016

Grant Date

Title

Related Topics

Intensive care medicine, Respiratory therapy, Respiratory physiology, Attachment theory, Medical signs

Status

Application

Latest RespiDx News

ISRAEL21c coverage helps RespiDX advance

Mar 29, 2016

Proposal for a simple pneumonia diagnostic tool meant to address epidemic in developing countries. March 22, 2015, 10:30 am The RespiDx team (Ian Solomon is second from right). Email The RespiDx team (Ian Solomon is second from right). Last month, ISRAEL21c reported that two Israeli startups – RespiDX and NanoVation GS — won seed grants from Grand Challenges Israel for their product ideas for diagnosing childhood pneumonia in low-resource regions. We recently received word from RespiDX that our coverage proved critical in promoting its concept to key organizations and corporations working to reduce childhood deaths from pneumonia in developing countries. “The article ISRAEL21c wrote describing our Respimometer project has been very helpful to us, and was used by Grand Challenges Canada to create connections for us to the relevant UN bodies, UNICEF, and a range of potential industrial partners,” says Ian Solomon, VP business development for the Profile Group of Companies  in Jerusalem. “Following this, the company we established for this project, RespiDx Ltd., is already in discussions with several of these bodies, so the article has been most useful.” He adds that ISRAEL21c’s article was the only one circulated to potential partners by Grand Challenges Canada, and that it came to their attention from an outside source. Respimometer is envisioned as a cross between a pacifier and a digital oral thermometer. The mouth stop just under the child’s nose would be embedded with sensors to measure breathing as a way of detecting pneumonia immediately. “We filed a patent and now we’re looking to use the grant to make a prototype and test it against existing means of measuring respiration rate to prove it’s good enough to be out in the market,” Solomon told ISRAEL21c. RespiDX has applied for a Bill & Melinda Gates Foundation grant and is seeking matching funds to run a test project in Africa in order to identify cultural and field conditions that could impact the final design of the reusable product and the training protocol for healthcare workers. “We also made contact with a researcher who has experience running trial projects with community health workers,” says Solomon. “The idea is to simply diagnose and also simply treat children right in their villages.”  

  • Where is RespiDx's headquarters?

    RespiDx's headquarters is located at Jerusalem.

  • What is RespiDx's latest funding round?

    RespiDx's latest funding round is Grant - II.

  • How much did RespiDx raise?

    RespiDx raised a total of $150K.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.